Iron and erythrocytes: Physiological and pathophysiological aspects

Oxidants in Biology: A Question of Balance

Volumn , Issue , 2008, Pages 167-181

  Ciccoli, Lucia ^a   Leoncini, Silvia ^a   Signorini, Cinzia ^a   Comporti, Mario ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

thalassemia; Band 3 protein; diabetes mellitus; erythrocytes; iron release; newborns; Oxidative stress

Indexed keywords

EID: 84893824116     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4020-8399-0_8     Document Type: Chapter

References (69)

1. Afanas'ev I. B., Dorozhko A. I., Brodskii A. V., Kostyuk V. A., Potapovitch A. I. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem. Pharmacol. 38:1763-1769;1989.
2. Aruoma O. I., Bomford A., Polson R. J., Halliwell B. Nontransferrin-bound iron in plasma from hemochromatosis patients: effect of phlebotomy therapy. Blood 72:1416-1419;1988.
3. Ben-Hur E., Rosenthal I., Granot Graziani Y. Inhibition of phthalocyanine-sensitized photohemolysis of human erythrocytes by quercetin. Photochem. Photobiol. 57:984-988; 1993.
4. Beppu M., Mizukami A., Nagoya M., Kikugawa K. Binding of anti-band 3 autoantibody to oxidatively damage erythrocytes. J. Biol. Chem. 265:3226-3233;1990.
5. Beppu M., Ando K., Kikugawa K. Poly-N-acetyllactosaminyl saccharide chains of band 3 as determinants for anti-band 3 autoantibody binding to senescent and oxidized erythrocytes. Cell. Mol. Biol. 42:1007-1024;1996.
6. Berger H. M., Mumby S., Gutteridge J. M. C. Ferrous ions detected in iron-overloaded cord blood plasma from preterm and term babies: implications for oxidative stress. Free Rad. Res. 22:555-559; 1995.
7. Bocci V., Pessina G. P., Paulesu L. Studies of factors regulating the ageing of human erythrocytes-III. Metabolism and fate of erythrocytic vesicles. Int. J. Biochem. 11:139-142; 1980.
8. Bracci R., Buonocore G. The antioxidant status of erythrocytes in preterm and term infants, Semin. Neonatol. 3:191-197; 1998.
9. Breuer W., Epsztejn S., Cabantchik Z. I. Dynamics of the cytosolic chelatable iron pool of K562 cells. FEBS Lett. 382:304-308; 1996.
10. Breuer W., Ronson A., Slotki I. N., Abramov A., Hershko C., Cabantchik Z. I. The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation. Blood 95:2975-2982, 2000.
11. Browne P., Shalev O., Hebbel R. B. The molecular pathobiology of cell membrane iron: the sickle red cell as a model. Free Rad. Biol. Med. 24:1040-1048;1998.
12. Brunori M., Falcioni G., Fioretti E., Giardina B., Rotilio G. Formation of superoxide in the autoxidation of the isolated αand β chains of human hemoglobin and its involvement in hemichrome precipitation. Eur. J. Biochem. 53:99-104; 1975.
13. Buonocore G., Perrone S., Gioia D., Gatti M. G., Massafra C., Agosta R., Bracci R. Nucleated red blood cell count at birth as an index of perinatal brain damage. Am. J. Obstet. Gynecol. 181:1500-1505;1999.
14. Cairo G., Pietrangelo A. Iron regulatory proteins in pathobiology. Biochem. J. 352:241-250; 2000.
15. Ciccoli L., Ferrali M., Rossi V., Signorini C., Alessandrini C., Comporti M. Hemolytic drugs aniline and dapsone induce iron release in erythrocytes and increase the free iron pool in spleen and liver. Toxicol. Lett. 110:57-66; 1999a.
16. Ciccoli L., Signorini C., Scarano C., Rossi V., Bambagini S., Ferrali M., Comporti M. Iron release in erythrocytes from patients with β-thalassemia. Free Rad. Res. 30:407-413; 1999b.
17. Ciccoli L., Rossi V., Leoncini S., Signorini C., Paffetti P., Bracci R., Buonocore G., Comporti M. Iron release in erythrocytes and plasma non protein-bound iron in hypoxic and non hypoxic newborns. Free Radic Res. 37:51-58; 2003.
18. Ciccoli L., Rossi V., Leoncini S., Signorini C., Blanco-Garcia J., Aldinucci C., Buonocore G., Comporti M. Iron release, superoxide production and binding of autologous IgG to band 3 dimers in newborn and adult erythrocytes exposed to hypoxia and hypoxia-reoxygenation, Biochim. Biophys. Acta 1672:203-213; 2004.
19. 2-isoprostanes are elevated in newborns and inversely correlated to gestational age, Free Radic. Biol. Med. 37:724-732; 2004.
20. 2 alpha: specific analysis of an isoeicosanoid as an index of oxidant stress in vivo, Br. J. Clin. Pharmacol. 42:15-19; 1996.
21. Dorrepaal C. A., Berger H. M., Benders M. J. N. L., Van Zoeren-Grobben D., Van de Bor M., Van Bel F. Nonprotein-bound iron in postasphyxial reperfusion injury of the newborn. Pediatrics 98:883-889; 1996.
22. Evans P. J., Evans R., Kovar I. Z., Holton A. F., Halliwell B. Bleomycin-detectable iron in the plasma of premature and full-term neonates. FEBS Lett. 303:210-212; 1992.
23. Ferrali M., Ciccoli L., Comporti M. Allyl alcohol-induced hemolysis and its relation to iron release and lipid peroxidation. Biochem. Pharmacol. 38:1819-1825;1989.
24. Ferrali M., Ciccoli L., Signorini C., Comporti M. Iron release and erythrocytes damage in allyl alcohol intoxication in mice. Biochem. Pharmacol. 40:1485-1490;1990.
25. Ferrali M., Signorini C., Ciccoli L., Comporti M. Iron release and membrane damage in erythrocytes exposed to oxidizing agents, phenylhydrazine, divicine and isouramil. Biochem. J. 285:295-301; 1992.
26. Ferrali M., Signorini C., Ciccoli L., Comporti M., Iron released from an erythrocyte lysate by oxidative stress is diffusible and in redox active form. FEBS Lett. 319:40-44; 1993.
27. Ferrali M., Signorini C., Caciotti B., Sugherini L., Ciccoli L., Giachetti D., Comporti M. Protection against oxidative damage of erythrocyte membrane by the flavonoid quercetin and its relation to iron chelating activity. FEBS Lett. 416:123-129; 1997.
28. Ferrali M., Signorini C., Ciccoli L., Bambagioni S., Rossi V., Pompella A., Comporti M. Protection of erythrocytes against oxidative damage and autologous immunoglobulin G (IgG) binding by iron chelator fluor-benzoil- pyridoxal hydrazone. Biochem. Pharmacol. 59:1365-1373;2000.
29. Flynn T. P., Allen D. W., Johnson G. J., White J. G. Oxidant damage of lipids and proteins of the erythrocyte membranes in unstable hemoglobin disease: evidence for the role of lipid peroxidation. J. Clinic. Invest. 71:1215-1223;1983.
30. 2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett. 368:225-229; 1995.
31. Gutteridge J. M. C. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett. 201:291-295; 1986.
32. Halliwell B., Gutteridge J. M. C. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 219:1-14; 1985.
33. Hershko H., Graham G., Bates G. W., Rachmilewitz E. Nonspecific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Brit. J. Haematol. 40:255-263; 1978.
34. Jay D, Hitomi H., Griendling K. K. Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med 40:183-192; 2006.
35. Kahane I. Cross-linking of red blood cell membrane proteins induced by oxidative stress in β-thalassemia. FEBS Lett. 85:267-270; 1978.
36. Kay M. M. B. Localization of senescent cell antigen on band 3. Proc. Natl. Acad. Sci. USA 81:5753-5757;1984.
37. Kay M. M. B., Goodman S. R., Sorensen K., Whitfield C. F., Wong P., Zaki L., Rudloff V. Senescent cell antigen is immunologically related to band 3. Proc. Natl. Acad. Sci. USA 80:1631-1635;1983.
38. Konijn A. M., Glickstein H., Vaisman B., Meyron-Holtz E. G., Slotki I. N., Cabantchik Z. I. The cellular labile iron pool and intracellular ferritin in K562 cells. Blood 94:2128-2134;1999.
39. Ladner R. C., Heidner E. J. and Perutz M. F. The structure of horse methaemoglobin at 2.0 Å. J. Mol. Biol. 114(1977), pp. 385-414.
40. Lee D. H., Liu D. Y., Jacobs D. R. Jr, Shin H. R., Song K., Lee I. K., Kim B., Hider R. C. Common presence of non-transferrin-bound iron among patients with type 2 diabetes. Diabetes Care 29:1090-1095;2006.
41. Li W., Xu L. H., Yuan X. M. Macrophage hemoglobin scavenger receptor and ferritin accumulation in human atherosclerotic lesions. Ann N Y Acad Sci. 1030:196-201; 2004.
42. Lloyd J. B., Cable H., Rice-Evans C. Evidence that desferrioxamine cannot enter cells by passive diffusion. Biochem. Pharmacol. 41:1361-1363;1991.
43. Low P. S., Waugh S. M., Zinke K., Drenckhahn D. The role of hemoglobin denaturation and band 3 clustering in red blood cell aging. Science 227:531-533; 1985.
44. Lubin B. H., Van de Berg J. J. M., Lewis R. A., Scott M. D. and Kuypers F. A. Unique properties of the neonatal red cell. In: M. Xanthou, R. Bracci and G. Prindull, Editors, Neonatal haematology and immunology II, Excerpta Medica, Amsterdam, pp. 79-89; 1993.
45. Lutz H. U., Bussolino F., Flepp R., Fasler S., Stammler P., Kazatchkine M. D., Arese P. Naturally occurring anti-band-3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes. Proc. Natl. Acad. Sci. USA 84:7368-7372;1987.
46. Macdonald V. W., Charache S. Differences in the reaction sequences associated with drug-induced oxidation of hemoglobins E, S, A, and F. J. Lab. Clin. Med. 102:762-772; 1983.
47. Miller D. M., Buettner G. R., Aust S. D. Transition metals as catalysts of "autoxidation" reactions. Free Rad. Biol. Med. 8:95-108; 1990.
48. Minotti G. Sources and role of iron in lipid peroxidation. Chem. Res. Toxicol. 6:134-146; 1993.
49. Monteiro H. P., Winterbourn C. C. Release of iron from ferritin by divicine, isouramil, acid-hydrolyzed vicine and dialuric acid and initiation of lipid peroxidation. Arch. Biochem. Biophys. 271:536-545; 1989.
50. Montuschi P., Barnes P. J., Roberts L. J. II, Isoprostanes: markers and mediators of oxidative stress, FASEB J. 18:1791-1800;2004.
51. Morrow J. D., Roberts L. J. II, The isoprostanes: current knowledge and directions for future research, Biochem. Pharmacol. 51:1-9; 1996.
52. Porter J. B., Abeysinghe R. D., Marshall L., Hider R. C., Singh S. Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy. Blood 88:705-713; 1996.
53. Puppo A., Halliwell B. Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Biochem. J. 249:185-190; 1988.
54. Reif D. W. Ferritin as a source of iron for oxidative damage. Free Rad. Biol. Med. 12:417-427; 1992.
55. Repka T., Shalev O., Reddy R., Yuan J., Abrahamov A., Rachmilewitz A., Low P. S., Hebbel R. P. Nonrandom association of free iron with membranes of sickle and β-thalassemic erythrocytes. Blood 82:3204-3210;1993.
56. Ryan T. P., Aust S. D. The role of iron in oxygen-mediated toxicities. Crit. Rev. Toxicol. 22:119-141; 1992.
57. Robson N., Brittain T. Heme stability in the human embryonic hemoglobins, J. Inorg. Biochem. 64:137-147; 1996.
58. Rossi V., Leoncini S., Signorini C., Buonocore G., Paffetti P., Tanganelli D., Ciccoli L., Comporti M. Oxidative stress and autologous immunoglobulin G binding to band 3 dimers in newborn erythrocytes. Free Radic Biol Med. 40:907-915; 2006a.
59. Rossi V., Tanganelli I., Leoncini S., Signorini C., Totagiancaspro D., Ciccoli L. Oxidative stress and autologous IgG binding to band 3 dimers in erythrocytes of diabetic subjects. Diabetologia 49:343; 2006b.
60. Sailaja Y. R., Baskar R., Saralakumari D. The antioxidant status during maturation of reticulocytes to erythrocytes in type 2 diabetics. Free Radic Biol Med 35:133-139; 2003.
61. Saugstad O. D. Mechanisms of tissue injury by oxygen radicals: implications for neonatal disease, Acta Paediatr. 85:1-4; 1996.
62. Scott M. D., Van de Berg J. J. M., Repka T., Rouyer-Fessard P., Hebbel R. P., Beuzard P., Lubin B. H. Effect of excess α-hemoglobin chains on cellular and membrane oxidation in model β-thalassemic erythrocytes. J. Clinic. Invest. 91:1706-1712;1993.
63. Signorini C., Ferrali M., Ciccoli L., Sugherini L., Magnani A. and Comporti M. Iron release, membrane protein oxidation and erythrocyte ageing. FEBS Lett. 262:165-170; 1995.
64. Sorata Y., Takahama U., Kimura M. Protective effect of quercetin and rutin on photosensitized lysis of human erythrocytes in the presence of hematoporphyrin. Biochem. Biophys. Acta 799:313-317; 1984.
65. Thomas C. E., Aust S. D. Rat liver microsomal NADPH-dependent release of iron from ferritin and lipid peroxidation. J. Free Rad. Biol. Med. 1:293-300; 1985.
66. Turrini F., Arese P., Yuan J., Low P. S. Clustering of integral membrane proteins of the human erythrocyte membrane stimulates autologous IgG binding, complement deposition, and phagocytosis. J. Biol. Chem. 266:23611-23617;1991.
67. Turrini F., Mannu F., Cappadoro M., Ulliers D., Giribaldi G., Arese P. Binding of naturally occurring antibodies to oxidatively and nonoxidatively modified erythrocyte band 3. Biochim. Biophys. Acta 1190:297-303; 1994.
68. Yuan X. M., Olsson A. G., Brunk U. T. Macrophage erythrophagocytosis and iron exocytosis. Redox Report 2:9-17; 1996a.
69. Yuan X. M., Anders W. L., Olsson A. G., Brunk U. T. Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis. Atherosclerosis 124:61-73; 1996b.